about
A Novel Diagnostic Target in the Hepatitis C Virus GenomeEpidemiological aspects of influenza A related to climatic conditions during and after a pandemic period in the city of Salvador, Northeastern BrazilProgress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project.Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.AIDS related malignancies in Brazil.Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.Establishing the reference range for T lymphocytes subpopulations in adults and children from Brazil.Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.Stroke correlates in chagasic and non-chagasic cardiomyopathies.Cosavirus infection in persons with and without gastroenteritis, BrazilDiabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort StudyRates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in BrazilGlucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from BrazilCoinfection by Hepatitis C Is Strongly Associated with Abnormal CD4/CD8 Ratio in HIV Patients under Stable ART in Salvador, Brazil.Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.Use of protein antigens for early serological diagnosis of leprosy.The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.Survival and Prognostic Factors for AIDS and Non-AIDS Patients with Non-Hodgkin's Lymphoma in Bahia, Brazil: A Retrospective Cohort Study.Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).Anogenital infection by Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected men and women in Salvador, Brazil.Prevalence of sexually transmitted infections among HIV-infected women in Brazil.Theories about evolutionary origins of human hepatitis B virus in primates and humans.Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: final results of two randomized phase III trials.Reproductive outcome in pregnant women with recurrent pregnancy loss.An outbreak of human Leishmania (Viannia) braziliensis infection.Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study.Survival Estimates and Mortality Risk Factors in a Cohort of HIV Vertically Infected Individuals in Salvador, Brazil.Spontaneous clinical resolution without specific treatment in mucosal leishmaniasis.Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).An unusual relapsing case of skin leishmaniasis.Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection.High degree of concordance between flow cytometry and geno2pheno methods for HIV-1 tropism determination in proviral DNA.Adherence to antiretroviral therapy of Brazilian HIV-infected children and their caregivers.Tuberculosis incidence among people living with HIV/AIDS with virological failure of antiretroviral therapy in Salvador, Bahia, Brazil.Increased expression of CD38 and HLADR in HIV-infected patients with oral lesion.Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy.Chronic symptoms and pulmonary dysfunction in post-tuberculosis Brazilian patients.Lymphocyte subset reference intervals in blood donors from northeastern Brazil.Use of new antiretroviral drugs and classes in Bahia, Brazil: a real life experience on salvage therapy of AIDS patients.Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women.
P50
Q27487878-5FE38E14-A137-4891-B88D-695E2E2A4CF0Q30361191-89D28245-474E-41DA-A7FB-FAC75583CABBQ30671133-A3F92663-CAA9-4FD3-907E-F660D2FBD25AQ33432690-A2FF119C-A049-4C7C-9D31-972CA9364186Q33793515-2674F311-E105-4D36-9B34-7C5D7CC0E992Q33870336-EF04E49B-996E-4C7B-9F48-B6DEDA170271Q33926456-0A5DE58E-BFB5-4491-826B-5F589E05CE64Q34163466-BF3AF446-BEC7-46C1-A062-D1FC44524CDEQ34241769-1FAB153F-2D6B-4140-B85E-5A0639FFDEDAQ35844710-562EEB30-7D79-4154-AE42-1CD9F5375988Q35890642-5DFBD0F2-B1F5-428F-874C-2F55878CAD6CQ35913979-96BDCF5D-5424-4658-9756-DC80FD1F0235Q35989755-235B1B97-EEA8-41BE-8763-CA8FDC776E74Q36015283-53D614A0-9930-45A0-83A6-1ADD66A39014Q36137104-DD41BBD3-B8EA-41B9-B04D-EC75E982F72BQ36313571-B8204754-680E-430D-B015-A2A9164EF11EQ37104439-028B8E3A-287E-4649-A750-81179A225484Q37316219-2212BFCB-F2F4-4AC6-9A6E-269A89679C9EQ37672616-77AE3084-08D4-4CCD-9D26-D9598F896E52Q37835539-DEEAF472-C6B7-4E29-AE52-A1611D55C558Q37847630-C5BB3FA1-9928-4322-843C-6AAA65E065F6Q38204086-E1FEA610-7817-4230-AD6A-CDA711BE13F4Q38470797-9948EFA5-0A77-4C0E-938A-E3B65F391651Q38933866-A5ED173F-608F-4482-9BC7-2E3AAF1B4EB8Q39010939-8F1DC319-923E-4289-ABD5-EB64AD30F310Q39014276-5AF18825-0A16-4245-AEF0-0613CAB04250Q39142671-774C32EF-E5DA-48FD-85E4-12B3F2C351E9Q39217372-209438FF-0DA9-4307-9A6F-F6B6C0D41E44Q39299818-5BF35DA4-3998-4AD9-8879-B6EDC3C1259DQ39299827-91552363-5B41-4BE9-8A16-581F878FB192Q39481239-78CE60E6-2797-4AE3-A62D-0DFE60A92549Q39529915-B5C27FF1-6382-486E-BE69-FF3A50BE466EQ39547136-F71E5CD7-D407-4640-B7F3-94714539A11EQ40154193-B38BB37A-8AE1-4582-A4B5-A335CCF68911Q40202946-0D090016-7F08-4A4D-9409-BEAB3173D794Q40311036-6A12E8AD-D7F7-4461-A54D-8BD3F4220DF9Q40645793-8948096F-484C-4137-B77F-E44DD59E1681Q41000499-9D564062-BDA2-44EE-8524-5BFB6613B574Q41724215-6C48FEC3-8BED-4B71-91F7-E73F5319CBDEQ41923659-B0296C1D-FEE2-444B-A31A-A21205B5AF71
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Eduardo Netto
@ast
Eduardo Netto
@en
Eduardo Netto
@es
Eduardo Netto
@nl
Eduardo Netto
@sl
type
label
Eduardo Netto
@ast
Eduardo Netto
@en
Eduardo Netto
@es
Eduardo Netto
@nl
Eduardo Netto
@sl
prefLabel
Eduardo Netto
@ast
Eduardo Netto
@en
Eduardo Netto
@es
Eduardo Netto
@nl
Eduardo Netto
@sl
P1053
D-1432-2013
P106
P1153
7003793691
P21
P214
6151963574600311339
P31
P3829
P496
0000-0003-1691-6761
P734
P735
P7859
viaf-6151963574600311339